Drug
Ketosteril
Ketosteril: highest development phase Post-Market, developed by Fresenius Kabi. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ketosteril® NCT00363987 | Post-Market | Diabetic Nephropathy |
| Ketosteril® NCT03077048 | Phase 1/2 | Renal Insufficiency, Chronic |
Latest
No recent events.
Follow Ketosteril on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.